{"path":"Images/Pasted image 20240201144135.png","text":"Table 4. Recommendations for nephroprotective measures Discontinue all nephrotoxic agents Consider avoiding radiocontrast agents Avoid colloids if possible Ensure volume status and perfusion pressure sw<11 Mean arterial pressures > 65 mmHg (higher values in patients with hypertension) CVP 8-12 mmHg Measure blood lactate levels ScvO2 >70% Intra-abdominal pressure < 15 mmHg Consider functional hemodynamic monitoring* Functional leg raising, arterial line TIE, TEE, PICCO in major surgeries Monitor serum-creatinine and urinary output Serum-creatinine daily and urinary output hourly Avoid hyperglycemia Blood glucose levels 110-150mg/dl *Expanding hemodynamic monitoring depends on the complexity of the surgical procedure. Evaluation of risk-benefitassessment is necessary. CVP, central venous pressure; PICCO, pulse contour cardiac output; SevO2, central venous oxygen saturation; SVV, stroke volume variation; TTE, tranesophageal echocardiography; TTE, transthoracic echocardiography.","libVersion":"0.3.2","langs":"eng"}